PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond

S Fattahi, F Amjadi-Moheb, R Tabaripour, GH Ashrafi… - Life Sciences, 2020 - Elsevier
Abstract PI3K/AKT/mTOR pathway is one of the most important signaling pathways involved
in normal cellular processes. Its aberrant activation modulates autophagy, epithelial …

[HTML][HTML] A recent review on cancer nanomedicine

PM Giri, A Banerjee, B Layek - Cancers, 2023 - mdpi.com
Simple Summary The advancement of nanotechnology over the last three decades has
given new hope to cancer management. The first FDA-approved nanomedicine (DOXIL) was …

Novel drug delivery systems as an emerging platform for stomach cancer therapy

U Hani, RAM Osmani, S Yasmin, BHJ Gowda, H Ather… - Pharmaceutics, 2022 - mdpi.com
Cancer has long been regarded as one of the world's most fatal diseases, claiming the lives
of countless individuals each year. Stomach cancer is a prevalent cancer that has recently …

Autophagy modulators: mechanistic aspects and drug delivery systems

S Tavakol, M Ashrafizadeh, S Deng, M Azarian… - Biomolecules, 2019 - mdpi.com
Autophagy modulation is considered to be a promising programmed cell death mechanism
to prevent and cure a great number of disorders and diseases. The crucial step in designing …

Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon

P Wu, Q Zhou, H Zhu, Y Zhuang, J Bao - BMC cancer, 2020 - Springer
Background Tumor recurrence and metastasis occur at a high rate in patients with colon
cancer. Identification of effective strategies for the treatment of colon cancer is critical …

Nanoparticles guided drug delivery and imaging in gastric cancer

GP Nagaraju, G Srivani, B Dariya, G Chalikonda… - Seminars in Cancer …, 2021 - Elsevier
Gastric cancer represents a deadly malignancy worldwide, yet current therapeutic regimens
remain ineffective. Nanoparticle (NP)-based solutions could allow the design of novel …

Nano drug delivery systems in upper gastrointestinal cancer therapy

J Salapa, A Bushman, K Lowe, J Irudayaraj - Nano Convergence, 2020 - Springer
Upper gastrointestinal (GI) carcinomas are characterized as one of the deadliest cancer
types with the highest recurrence rates. Their treatment is challenging due to late diagnosis …

New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer

X Zhu, T Su, S Wang, H Zhou, W Shi - Frontiers in Oncology, 2022 - frontiersin.org
With the development of materials science and biomedicine, the application of
nanomaterials in the medical field is further promoted. In the process of the diagnosis and …

Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer

L Zhang, V Aragon‐Sanabria, A Aditya… - Advanced …, 2023 - Wiley Online Library
Despite advances by recently approved antibody‐drug conjugates in treating advanced
gastric cancer patients, substantial limitations remain. Here, several key obstacles are …

Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes

W Liang, Y Dong, R Shao, S Zhang, X Wu… - Journal of Drug …, 2022 - Taylor & Francis
Osteosarcoma (OS) is one of the most common primary bone malignancies in children and
adolescents. The toxicity to healthy tissues from conventional therapeutic strategies …